EMD SERONO, INC. for EMD SERONO INC
What was lobbied
11 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 1209: Reforming Evergreening and Manipulation that Extends Drug Years Act; all provisions of the bill S. 1416: Affordable Prescriptions for Patients Act of 2019; all provisions of the bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
| THOMAS CORDREY ROBERGE | — |
| WENDY SUSSMAN | — |
Chemicals/Chemical Industry CHM
General discussions regarding the Toxic Substances Control Act (TSCA) - Section 5 Pre-manufacture Notice (PMN)
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Animals ANI
Federal Drug Administration Commissioner Letter regarding Predictive Toxicology Roadmap
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Trade (domestic/foreign) TRD
General Discussions regarding United States-Switzerland Trade Agreement General Discussions regarding United States-Mexico-Canada Agreement (USMCA) - issues relating to free and fair trade agreements and zero lapse between NAFTA and USMCA
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Waste (hazardous/solid/interstate/nuclear) WAS
General Discussions related to impact of Single-Use Plastics ban
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Tariff (miscellaneous tariff bills) TAR
General discussions regarding impacts of Section 301 (China) and Section 232 Tarrifs
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Automotive Industry AUT
General discussions regarding Section 232 Automotive Tarrifs
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Health Issues HCR
H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions of the bill H.R. 1046: Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill H.R. 2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act; all provisions of the bill H.R. 2296: Fair Accountability and Innovative Research (FAIR) Drug Pricing Act of 2019; all provisions of the bill S. 102: Prescription Drug Price Relief Act of 2019; all provisions of the bill S. 340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions of the bill S. 377: Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill S. 447: Keep Americans Safe Act; all provisions of the bill S. 1895: Lower Health Care Costs Act; all provisions of the bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
| THOMAS CORDREY ROBERGE | — |
| WENDY SUSSMAN | — |
Medicare/Medicaid MMM
H.R. 1046: Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill S. 102: Prescription Drug Price Relief Act of 2019; all provisions of the bill S. 377: Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill S. 1391: Fair Accountability and Innovative Research Drug Pricing Act of 2019; all provisions of the bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
| THOMAS CORDREY ROBERGE | — |
| WENDY SUSSMAN | — |
Labor Issues/Antitrust/Workplace LBR
General discussions regarding H.R.2353 - Strengthening Career and Technical Education for the 21st Century Act (115th Congress) and Workforce Development issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Pharmacy PHA
H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions of the bill H.R. 1034: Phair Pricing Act of 2019; all provisions of the bill H.R. 1035: Prescription Drug Price Transparency Act; all provisions of the bill H.R. 2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act; all provisions of the bill H.R. 2296: Fair Accountability and Innovative Research (FAIR) Drug Pricing Act of 2019; all provisions of the bill S. 102: Prescription Drug Price Relief Act of 2019; all provisions of the bill S. 340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions of the bill S. 447: Keep Americans Safe Act; all provisions of the bill S. 474: Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019; all provisions of the bill S. 476: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019 ; all provisions of the bill S. 1209: Reforming Evergreening and Manipulation that Extends Drug Years Act; all provisions of the bill S. 1391: Fair Accountability and Innovative Research Drug Pricing Act of 2019; all provisions of the bill S. 1416 - Affordable Prescriptions for Patients Act of 2019; all provisions of the bill S. 1895: Lower Health Care Costs Act; all provisions of the bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
| THOMAS CORDREY ROBERGE | — |
| WENDY SUSSMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.